The protein encoded by this gene belongs to the family of patatin-like phospholipases (PNPLA), which are characterized by the presence of a highly conserved so-called "patatin domain".
The human genome encodes nine enzymes belonging to the patatin-like phospholipase domain-containing lipase (PNPLA)/Ca2+-independent phospholipase A2 (iPLA2) family. Although most PNPLA/iPLA2 enzymes are widely distributed and act as (phospho)lipases on phospholipids or neutral lipids to play a homeostatic role in lipid metabolism, the function of PNPLA1 remained unknown until a few years ago. Only recently, mutations in the human PNPLA1 gene were shown to be associated with autosomal recessive congenital ichthyosis (ARCI) Pichery M et al (2017). PNPLA1 is specifically expressed in differentiated keratinocytes and plays a critical role in the biosynthesis of ω-O-acylceramide, a specific class of sphingolipids essential for skin barrier function. PNPLA1 functions as a unique transacylase that specifically transfers linoleic acid from triglyceride to ω-hydroxy fatty acid in ceramide resulting in ω-O-acylceramide (Hirabayashi Tet al. 2019).
Omega-hydroxyceramide transacylase involved in the synthesis of omega-O-acylceramides (esterified omega-hydroxyacyl sphingosine; EOS), which are extremely hydrophobic lipids involved in skin barrier formation. PNPA phospholipase catalyzes the final step in the synthesis of omega-O-acylceramides by transferring linoleic acid from triglycerides to an omega-hydroxyceramide. Omega-O-acylceramides are required for the biogenesis of lipid lamellae in the stratum corneum and the formation of the cornified lipid envelope, which is essential for the barrier function of the epidermis. These lipids also play a role in the differentiation of keratinocytes.